Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Parallel Group Study ◽

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793478299 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Efficacy and Safety of Low Dose Desmopressin Orally Disintegrating Tablet in Men with Nocturia: Results of a Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study

The Journal of Urology ◽

10.1016/j.juro.2012.12.112 ◽

2013 ◽

Vol 190 (3) ◽

pp. 965-972 ◽

Cited By ~ 50

Author(s):

Jeffrey P. Weiss ◽

Sender Herschorn ◽

Cerasela D. Albei ◽

Egbert A. van der Meulen

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995301.793478300 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793474892 ◽

2013 ◽

Author(s):

Howard Goldman ◽

Alana M Murphy

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Re: Efficacy and Safety of Low Dose Desmopressin Orally Disintegrating Tablet in Women with Nocturia: Results of a Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study

The Journal of Urology ◽

10.1016/j.juro.2013.08.116 ◽

2014 ◽

Vol 191 (3) ◽

pp. 875-876

Author(s):

Peter P. Petros

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793476156 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995301.793486187 ◽

2013 ◽

Author(s):

Alexis Te ◽

Bilal Chughtai

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Efficacy and Safety of Low Dose Desmopressin Orally Disintegrating Tablet in Women with Nocturia: Results of a Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study

The Journal of Urology ◽

10.1016/j.juro.2013.02.037 ◽

2013 ◽

Vol 190 (3) ◽

pp. 958-964 ◽

Cited By ~ 50

Author(s):

Peter K. Sand ◽

Roger R. Dmochowski ◽

Jyotsna Reddy ◽

Egbert A. van der Meulen

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort

International Journal of Colorectal Disease ◽

10.1007/s00384-019-03416-w ◽

2019 ◽

Vol 34 (11) ◽

pp. 1971-1978

Author(s):

Raunak Jay Soman ◽

Malisetty Venkat Swamy

Keyword(s):

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group ◽

Gastrointestinal Discomfort

A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Assess the Efficacy and Safety of Nebivolol, a Novel β-Blocker, in Patients With Mild to Moderate Hypertension

Journal of Clinical Hypertension ◽

10.1111/j.1524-6175.2007.06679.x ◽

2007 ◽

Vol 9 (9) ◽

pp. 667-676 ◽

Cited By ~ 39

Author(s):

Robert J. Weiss ◽

Michael A. Weber ◽

Albert A. Carr ◽

Will A. Sullivan

Keyword(s):

Moderate Hypertension ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group ◽

Β Blocker